Background: Cisplatin is considered a potent chemotherapeutic drug used in clinical oncology but causes testicular damage as a side effect. Erdosteine is a mucolytic drug possessing an antioxidant capacity. Aim of the Work: The present study was planned to evaluate the possible protective effect of erdosteine against cisplatin-induced testicular toxicity in rats. Material and Methods: Forty adult male albino rats were divided into four groups, ten rats each: control, erdosteine-treated (50 mg/kg body weight/day, orally for 7 days), cisplatin-treated (a single dose of 7mg/ kg intraperitoneally) and erdosteine/cisplatin-treated. Erdosteine was administered 24h before cisplatin injection and was continued until animal sacrifice. Six days after cisplatin administration, all rats were anaesthetized with ether. The scrotum of each animal was incised and the testes were removed and processed to be examined by both the light and scanning electron microscopy. Results: Examination of the testicular specimens of the cisplatin-treated group revealed severe testicular damage with significant reduction in the tubular diameter and germinal epithelium thickness compared to the control group. Shrunken tubules, germ cell loss and apoptotic changes in most of the cells, especially the primary spermatocytes and round spermatids were noticed. The mature spermatids appeared markedly decreased in number and the existing ones showed abnormal forms. Increased interstitial edema and apparent decrease in the Leydig cells were also observed. Erdosteine administration before cisplatin showed amelioration of the testicular architecture. Despite the mild degenerative changes in some spermatogenic cells, cell loss was markedly decreased and most of the tubular lumina were full of mature spermatids. Apparent increase in the Leydig cells and decreased interstitial edema was also noticed. Conclusions: Erdosteine partially protected the rat testes against the cisplatin-induced toxicity most probably via its potent antioxidant and radical scavenging activities.
INTRODUCTION
Cisplatin (Cis-diamminedichloroplatinum-II, CP), a chemotherapeutic agent has been successfully used in clinical oncology against diverse types of malignancies, including cancers of lung, bladder, ovary and testis (Rosenberg, 1999) . Testicular germ cell tumors are the most common malignancy in adult men between 15 and 45 years of age (Fossa, et al. 1988) . The cytotoxic effects of cisplatin and others chemotherapeutic drugs result, in part, from their interaction with DNA inhibiting fundamental cellular processes including replication, transcription and DNA repair with subsequent apoptosis (Wozniak and Blasiak, 2002) . Moreover, there is much evidence that the binding of cisplatin to non-DNA targets (especially proteins) may contribute to its cytotoxic mechanism of action. On the other hand, the dose of the drug and the metabolic condition of the cell subjected to cisplatin, may determine that the cancer cells die through apoptosis or cell necrosis (Gonzalez, et al. 2001; Fuertes, et al. 2003) .
Despite the potent antineoplastic action of cisplatin, it induced severe side effects including ototoxicity, gonadal toxicity, peripheral neuropathy and nephrotoxicity (Stadnicki, et al. 1975; Drasga, et al. 1983; Thompson, et al. 1984; Appenroth, et al. 1988) . Cisplatin chemotherapy results in azoospermia in most men, with a recovery of spermatogenesis in about 50% after 2 years and 80% after 5 years and the rest are rendered permanently infertile. These toxic effects led researchers to additional methods that could preserve fertility in men undergoing traditional anticancer therapy. Hormonal manipulation to enhance recovery of spermatogenesis and cryopreservation of testicular tissue were suggested (Howell and Shalet, 2005) .
Cisplatin cytotoxicity is also believed to be a result of generation of free radicals and induction of oxidative injury (Baliga, et al. 1999) . The overproduction of reactive oxygen species (ROS) results in defects in the integrity of the cell membrane of spermatozoa, as a result of lipid peroxidation, error in spermiogenesis and detrimental effects on sperm functions (Sanocka and Kurpisz, 2004) . Many antioxidant agents have been studied in experimental and clinical trials to reduce or prevent cisplatin-induced testicular toxicity (Choudhury and Jagdale, 2002; Ateşşahin, et al. 2006; Türk, et al. 2008) .
Erdosteine is a mucolytic drug that has been used in the treatment of chronic obstructive pulmonary diseases. The antioxidant and free radical scavenging capacity of erdosteine has been studied in the recent years. These protective activities were via its active metabolites (Braga, et al. 2000; Fadillioglu and Erdogan, 2003) . Erdosteine proved to ameliorate the cisplatin-induced renal failure in a dose-dependent manner in rats (Özyurt, et al. 2004) . So, the aim of the present study was to evaluate the possible protective effect of erdosteine on the testes of cisplatintreated albino rats using light and scanning electron microscopy.
MATERIAL AND METHODS
Animals: Forty adult male albino rats weighing 200-250 gm were used in the present study. The animals were kept in the animal house in the Medical Research Center and Bilharizial Researches, Faculty of Medicine, Ain Shams University hospitals. Animals were housed in separate cages under conventional and controlled conditions (12/12 light / dark cycle; 23-25c). The rats were maintained on standard laboratory diet with free access to water.
Drugs:
Cisplatin (cisplatin/ Merck, Merck generiques) was obtained as a solution (50 mg / 50 ml isotonic solution) and administrated as a single intraperitoneal injection (i.p.) in a dose of 7 mg/ kg body wt. Erdosteine (Mucotec/ Global Napi pharmaceuticals, Egypt) was obtained as capsules (150 mg). Capsules were dissolved in distilled water and given orally by gastric intubation as a single daily dose of 50 mg/kg body wt for a week. The first dose was given 24h prior to cisplatin injection and was continued for 6 days (Özyurt, et al. 2004 ).
Experimental design: Animals were randomly divided into four equal groups, 10 rats each.
Group I ( • Control):
Rats only received distilled water in a dose of 0.5ml/ rat/ day.
Group II (Erdosteine-treated): •
Rats received a single oral daily dose of erdosteine dissolved in distilled water) 0.5ml/ rat/ day) for 7 days.
Group III (Cisplatin-• treated): Rats were injected i.p. with a single dose of cisplatin Group IV (Erdosteine/ Cisplatin-treat-• ed): Rats were given a single dose of erdosteine 24h before cisplatin injection and continued until the sacrifice of the animals.
After six days of cisplatin administration, animals of all groups were anaesthetized with ether. The scrotum of each animal was incised. The testes were exposed and dissected. The right testis of each rat of each group was fixed in Bouin's liquid for 48 hours, sliced and processed for paraffin embedding. Sections of 5-7um were cut and stained with Hematoxyline and Eosin (Bancroft and Gamble, 2002) for their histopathological examination. The left testis of each rat of each group was immersed in 2.5 % buffered gluteraldehyde for 24 hours. Some specimens were processed to prepare to semithin sections. Other specimens were processed to be examined by scanning electron microscope. For preparation of semithin sections, tissue samples (1mm) were washed 3 times in phosphate buffer at PH 7.4, post fixed in 1% osmium tetraoxide for 1-2 hours. After dehydration in ascending grades of alcohol, the specimens were cleared in three changes of propylene oxide and finally embedded in gelatin capsules filled with fresh spurr-premix. The capsules were kept in the oven at 60oc for 48 hours for polymerization. Semithin sections of 0.5-1μm were cut using a glass knife and stained with toluidine blue to be examined by light microscopy. For scanning electron microscopic study, the buffered gluteraldehyde fixed tissue samples were dehydrated in ascending grades of ethyl alcohol (50%-70%-80%-90%-100%). The tissues were then further dehydrated in a mixture of 1:1 absolute alcohol and acetone 100% and then in 100% acetone twice; fifteen minutes for each. The specimens were then dried at critical point using liquid carbon dioxide in BALTEK CPD030 critical point dryer. The specimens were fixed on aluminum stubs and then sputter coated with gold using BALTEK-SCD005. Some specimens were cut with freeze fracture after immersion in liquid nitrogen. The testes of all groups were examined using scanning electron microscope Philips XL30 (Robinson, et al. 1987) .
Histomorphometric study: In each group, the transverse sections of the testes stained with Hematoxyline and eosin were examined by an image analyzer computer system using the soft ware Leica Quin 500 MC program. Ten random nonoverlapping fields/ testis specimen/ group were examined at 100x magnification and the tubular diameter and the height of the germinal epithelium of the examined seminiferous tubules were measured. The readings were obtained for each group and the mean values were calculated.
Statistical analysis: All data were collected and analyzed using the Statistical Package for the Social Sciences (SPSS) software program (version 13; SPSS Inc., Chicago, IL, USA). All values were expressed as mean ± SEM (standard error of mean). Student's t-test was used to compare the mean of the four groups. Probability (P) value was considered statistically significant if < 0.05 and highly significant if <0.01.
RESULTS

I-Histological Results
Light microscopic examination of the stained sections of the control group (Group I) revealed that the parenchyma of the testis was formed of numerous oval or rounded seminiferous tubules (STs) with narrow interstitial tissue spaces in between. Each tubule was surrounded by a regular thin basement (limiting) membrane and lined by five or six layers of spermatogenic cells in addition to the supporting Sertoli cells ( Fig. 1-A) . The germinal epithelium consisted of spermatogonia, primary spermatocytes, hardly detected secondary spermatocytes, young (round) and mature (elongated) spermatids ( Fig. 1-B) . The spermatogonia lay in contact with the basement membrane beside the Sertoli cells. Mitotic figures could be detected in some spermatogonia. The primary spermatocytes represented the next one or two rows of cells. They were large round cells having nuclei with coarse chromatin (pachytene stage) (Figs. 2-A, B). Next to the primary spermatocytes, the round spermatids were staked in three to four layers. They possessed lightly stained cytoplasm and round nuclei with pale granular chromatin. Mature (late or elongated) spermatids appeared in most of tubules with flattened, elongated nuclei and their tails were directed towards the lumen. The Sertoli cells rested on the basement membrane and almost extended to the lumen. They were pyramidal in shape with large pale oval nuclei with prominent nucleoli (Figs. 1-B, 2-A). In the interstitial spaces, the Leydig cells were observed singly or in groups embedded in loose connective tissue that was richly supplied by blood capillaries. They showed either round or oval nuclei with prominent nucleoli (Figs. 1-B, 2-B). Scanning electron microscopic examination of the control group showed several round seminiferous tubules with regular outlines and separated by narrow interstitial spaces ( Light and scanning microscopic examination of erdosteine-treated group (Group II) did not reveal any apparent histological differences between this group and the control one. All of the spermatogenic cell types constituting the successive stages of spermatogenesis were observed. The lumina of most of the seminiferous tubules were occupied by mature elongated spermatids (Figs. 5, 6-A). The latter showed oval heads and elongated straight tails of apparently similar thickness to the control group (Fig. 6-B) .
Under Light microscopy, sections of the cisplatin-treated group (Group III) showed severe testicular damage and extensively wide interstitial pied with spermatogenic cells while few appeared empty and completely depleted of cells B) . Intercellular spaces were observed in between the germ cells ( Fig. 13-A) . The young spermatids appeared polymorphic in shape. The mature ones showed apparent decrease in number as compared to the control group. Most of the elongated spermatids exhibited abnormal forms, thin short or forked tails (Figs. 13-B) .
Light microscopic examination of the stained sections of erdosteine / cisplatin -treated group (Group IV) revealed maintenance of the general architecture of the tubules with preservation of the normal height of germinal epithelium in addition to the diminution of the intertubular spaces as compared to group III (Fig. 14) . Moreover, the interstitial tissue showed decreased vacuolation and abundant Leydig cells (Fig. 15) . However, the improvement was not complete, as some tubules showed mild intercellular spaces as well as degenerative changes in some germ cells. Few primary spermatocytes showed lightly stained nuclei and ill-defined nuclear membrane. Some round spermatids showed small, dark and pyknotic nuclei. (Figs. 16-A, B) . Scanning electron microscopic examination of group IV showed that most of the seminiferous tubules had regular outlines and the germinal epithelium showed full height. The lumina of some of the tubules were occupied with mature spermatids while others appeared free (Figs. 17-A, B) .
II-Morphometric Results:
Statistical analysis of the mean values of the seminiferous tubular diameter and the germinal epithelial height in the erdosteine-treated group (Group II) revealed insignificant change (P < 0.5) in comparison to the control one. Cisplatin-treated group (Group III) showed a highly significant decrease (P <0.001) in the mean diameter of the seminiferous tubules and the germinal cell height compared to the control group. Erdosteine treatment before cisplatin (Group IV) revealed insignificant increase in the tubular diameter (P <0.2) as well as the germinal epithelial height (P <0.1) compared to cisplatintreated group (Tables 1, 2). spaces. Seminiferous tubules exhibited various degrees of affection; focal depletion of germ cells ,detachment of the germinal epithelium towards the lumina, or showed shrinkage with irregular basement membrane (Figs. 7-A, B) . Moreover, some of them were lined with few degenerated cells and their lumina were filled with acidophilic hyaline material (Fig. 7-C) , while others appeared distorted with loss of a part of their basement membrane (Figs.7-A, D) . Severely affected tubules showed remnants of degenerated cells with cytoplasmic dense bodies resting on a thickened and wrinkled basement membrane. The primary spermatocytes appeared small in size with irregular outlines. Most of the round spermatids showed highly vacuolated cytoplasm and ruptured cell membrane. Wide intercellular spaces among the spermatogenic cells were encountered as well ( Fig. 8-A) . Some of these tubules also showed areas completely depleted of germ cells and the Sertoli cells were the only cell type observed lining the tubules. Few degenerated cells were seen exfoliated towards the lumen (Fig. 8-B) . The spermatogonia were hardly detected in the severely affected tubules (Figs. 8-A, B) .
However, some of the seminiferous tubules showed normal height of the germinal epithelium but most of spermatogenic cell types exhibited morphological abnormalities. Primary spermatocytes appeared swollen with either densely stained cytoplasm and large-sized hyperchromatic nuclei or lightly stained cytoplasm and nuclei with ill-defined nuclear membranes (Figs. 9, 10 ). The round spermatids showed ring-shaped, sharp delineated and condensed marginal chromatin. Remnants of degenerated elongated spermatids were also observed (Fig. 9 ) Moreover, Adluminal apoptotic bodies were detected (Fig. 10) . The dilated interstitial spaces showed scanty number of Leydig cells, accumulation of intercellular vacuolated material in addition to dilated and congested interstitial blood vessels (Fig. 11) . Scanning electron microscopic examination of the sections of group III revealed that the majority of seminiferous tubules appeared compressed with wrinkled basement membrane. Most of them were occu- H & E; X400 Table 2 : mean height of the tubular germinal epithelium in different groups.
-P* value in each group (II, III, IV) was in comparison with the control value, P** value in group IV was compared with group III.
-N.S. = non significant; P < 0.001 was regarded highly significant (H.S). -P* value in each group (II, III, IV) was in comparison with the control value, P** value in group IV was in comparison with group III.
Groups
-N.S. = non significant; P < 0.001 was regarded highly significant (H.S). (Fig.2-B) . Notice the wide and vacuolated interstitial tissue (I) and the dilated congested interstitial blood vessel (arrow). Toluidine blue; X1000 (Fig.10) . Toluidine blue; x1000
DISCUSSION
Spermatogenic cells are targeted by cytotoxic agents because of their high mitotic activity. The chance of recovery of spermatogenesis and also the extent and speed of recovery are related to the agent used and the dose received (Ishikawa, et al. 2004) . Exposure to cisplatin results in impaired spermatogenesis with temporary azoospermia and, sometimes permanent infertility in male patients (Colpi, et al. 2004) . In the present research, examination of the testes of the cisplatin-treated rats' revealed severe testicular damage with a highly significant decrease in the diameter of the seminiferous tubules and the height of the germinal epithelium as compared to the control group. The primary spermatocytes appeared swollen with hyperchromatic or pale stained nuclei and ill-defined nuclear membrane. Some of the round spermatids showed nuclei with ring-shaped condensed marginal chromatin while the others showed highly vacuolated cytoplasm and ruptured cell membrane. Adluminal apoptotic bodies were also observed. Allen et al. (1997) found that the striking apoptotic changes observed by light microscope included cell shrinkage up to 30%, crescent-shaped masses of condensed chromatin adjacent to the nuclear envelope, and cytoplasmic and nuclear fragmentation leading to apoptotic bodies. Seeman et al. (2003) mentioned that administration of cisplatin resulted in elevated germ cell apoptotic rate with subsequent elimination of germ cells. Necrosis was also recorded (Cepeda, et al. 2007 ).
In the present study, some of the severely affected tubules showed shrinkage associated with severe degenerative changes in most of the germ cells. Other tubules showed germ cell depletion and some areas appeared lined only with Sertoli cells. Spermatogonia were hardly detected. Schrader et al. (2002) observed that human stem cell spermatogonia (type A) survived chemotherapy and suggested that they formed the basis for the recovery of spermatogenesis. However, high doses or prolonged duration of administration could destroy the spermatogonia leading to sustained or irreversible failure of germ cell production and consequently infertility. Boekelheide (1993) reported that cell vacuolation, apical sloughing, shedding of cellular material into the lumen and the massive germ cell loss were all manifestations of Sertoli cell injury. Spermatogenesis is supported and regulated by Sertoli cells. One of the Toluidine blue; X400 B-A higher magnification of the previous figure showing degenerative changes in some spermatogenic cells. Note the lightly stained nuclei and the ill defined nuclear membrane of primary spermatocytes (p). Notice also the round spermatids with small pyknotic nuclei (arrow).
Toluidine blue; X1000 (Pogach, et al. 1989; Sawhney, et al. 2005) .
In the present work, the examined sections of cisplatin-treated testes showed scanty Leydig cells, widening of interstitial spaces and accumulation of intercellular vacuolated material. Congested and dilated interstitial blood vessels were also noticed. In accordance with the present findings, Lirdi et al. (2008) mentioned that telangiectasia followed by endothelial disruption induced interstitial edema in cisplatin-treated rats. Aydiner et al. (1997) reported that cisplatin not only induced significant reduction in the Leydig cells but also resulted in alterations in their morphology. Amin and Hamza (2006) added that a decrease in number of Leydig cells and subsequently decreased levels of testosterone may affect directly or indirectly the interstitial tissue and lymphatic spaces provoking interstitial testicular edema. In the current study, light and scanning microscopic examination of the cisplatin-treated group revealed apparent decrease in the mature spermatids and the existing ones appeared as luminal cell remnants or exhibited abnormal forms. The present findings are in agreement with those of Ateşşahin et al. (2006) who explained them by the cisplatin-induced generation of reactive oxygen species (ROS). The oxidative stress can overwhelm the antioxidant defense systems and initiate changes in lipid and/ or protein layers of sperm plasma membranes. Additionally, changes in sperm DNA can be induced leading to its denaturation and fragmentation (Sanocka and Kurpisz, 2004) .
Recently, much attention has been focused on the protective effects of antioxidants against cisplatin-induced toxicity (Amin and Hamza, 2006; Ateşşahin, et al. 2006 and Lirdi, et al. 2008) . Erdosteine has been used as a mucolytic drug and as an enhancer of respiratory ventilation in the treatment of patients with chronic obstructive lung diseases. Erdosteine, which is a thiol derivative, possesses 2 blocked sulfhydryl groups which are released following first-pass metabolism. It exhibits a potent antioxidant and radical scavenging capacity. The structural feature responsible for its protective activities is the -SH group after its hepatic metabolism (Dechant and Noble, 1996; Braga, et al. 2000; Fadillioglu and Erdogan, 2003) . The most common side-effect of this group of drugs (mucolytics, such as N-acetylcysteine) is the gastric mucosal irritation. However, erdosteine is associated with a low incidence of adverse events because its mucolytic effect emerges after hepatic metabolism. A previous study indicated that the tolerable dose of erdosteine without side effects was 900 mg/day in humans and 500-1000 mg/kg/day in rats (De Giovanni, et al. 1991) . Özyurt et al. (2004) investigated the optimum dosage to ameliorate cisplatin -induced nephrotoxicity in rats. Three different doses of erdosteine were tested 25, 50 &75 mg/kg. The suggested optimum dose was 50 mg/kg which was used in the present work. Erdosteine was administered orally 24 hours before a single cisplatin i.p. injection and continued until the end of the present experiment (i.e.7 days). Histological examination of the sections of erdosteine/cisplatin-treated rats showed maintenance of their general architecture. Preservation of the normal height of germinal epithelium as well as diminution of the intertubular spaces was observed. The tubules appeared lined with all types of spermatogenic cells up to mature spermatids indicating complete process of spermatogenesis. Moreover, a reduction of the interstitial edema associated with an apparent increase in the Leydig cells as compared to the cisplatin-treated group was noticed. Although degenerative changes in some germ cells were detected, cell depletion was markedly decreased. Therefore, prophylactic erdosteine treatment conferred partial protection against cisplatin-induced testicular toxicity as it previously proved to ameliorate the cisplatin-induced renal failure (Özyurt, et al. 2004 ).
In conclusion, erdosteine seems to be a promising protective drug against cisplatin-induced toxicities in rats. Further studies are recommended to investigate the protective effects of erdosteine against cisplatin in humans.
